BDSX · Biodesix Inc
United States · RS rating 89 · As of 2026-10-14
| Price | 23.99 USD |
|---|---|
| 1-day change | -4.0% |
| RS rating (overall / 1M / 3M / 12M) | 89 / 18 / 91 / 98 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 48 / 48 / 60 |
| Industry group (rank) | Medical-Services (44) |
| EPS growth Q/Q | +57.8% |
| Sales growth Q/Q | +32.1% |
| Distance from 52-week high | +21.6% |
| Market cap (USD) | $100.7M |